Glenton C, Santesso N, Rosenbaum S, et al. Presenting the results of Cochrane Systematic Reviews to a consumer audience: a qualitative study. Med Decis Making. 2010;30(5):566-577.
Althabe F, Marti SG, Vinacur J, Belizan JM. New modelled estimates of maternal mortality. Lancet. 2010;375(9730):1966-1967; author reply 1968.
New modelled estimates of maternal mortality Ver más »
F. Tinajeros,L. R. Ares,V. Elías,L. Reveiz,F. Sánchez,M. Mejía,R. Hernández and R. Revollo. [Health-worker barriers to syphilis screening in pregnant women in Bolivia’s Los Andes network]. Rev Panam Salud Publica. 2017;41:10.26633/rpsp.2017.21.
Rubinstein A, Colantonio L, Bardach A, et al. [Estimate of the cardiovascular disease burden attributable to modifiable risk factors in Argentina]. Rev Panam Salud Publica. 2010;27(4):237-245.
Reveiz L, Cortes-Jofre M, Asenjo Lobos C, et al. Influence of trial registration on reporting quality of randomized trials: study from highest ranked journals. J Clin Epidemiol. 2010;63(11):1216-1222.
Bernardini-Zambrini D, Barengo N, Bardach A, Hanna M, Nunez JM. [Emigrate or not? How would the next Spanish generation of physicians decide? A study on emigration-related reasons and motivations of advanced medical students in 11 Universities in Spain]. Aten Primaria. 2011;43(5):222-226.
Rojas JI, Romano M, Ciapponi A, Patrucco L, Cristiano E. Interferon Beta for primary progressive multiple sclerosis. Cochrane Database Syst Rev. 2010(1):CD006643.
Interferon Beta for primary progressive multiple sclerosis Ver más »
Lewin S, Oxman AD, Lavis JN, Fretheim A, Garcia Marti S, Munabi-Babigumira S. SUPPORT tools for evidence-informed policymaking in health 11: Finding and using evidence about local conditions. Health Res Policy Syst. 2009;7 Suppl 1:S11.
Augustovski FA, Irazola VE, Velazquez AP, Gibbons L, Craig BM. Argentine valuation of the EQ-5D health states. Value Health. 2009;12(4):587-596.
Argentine valuation of the EQ-5D health states Ver más »
Augustovski F, Iglesias C, Manca A, Drummond M, Rubinstein A, Marti SG. Barriers to generalizability of health economic evaluations in Latin America and the Caribbean region. Pharmacoeconomics. 2009;27(11):919-929.
